What is Magnesium Glycinate?
Magnesium glycinate is a chelated form of magnesium bound to the amino acid glycine, marketed as a dietary supplement with approximately 93.75% active ingredient, though it lacks FDA evaluation for therapeutic claims and has no established clinical efficacy data for any medical condition. 1
Chemical Composition and Formulation
Magnesium glycinate (also called magnesium bisglycinate or magnesium diglycinate) consists of elemental magnesium bound to glycine molecules. The FDA labels this as a dietary supplement rather than a medication, with the standard disclaimer that it is "not intended to diagnose, treat, cure, or prevent any disease." 1 The formulation is promoted for supporting energy production, enzyme activity, nerve and muscle function, cardiovascular health, and bone maintenance. 1
Critical Evidence Gap
The most important clinical fact is that magnesium glycinate has never been evaluated in randomized controlled trials for any medical indication. The 2023 AGA-ACG guidelines explicitly state: "Only MgO has been evaluated in RCTs; the bioavailability and clinical efficacy of other formulations of magnesium (eg, citrate, glycinate, lactate, malate, sulfate) for CIC are unknown." 2
This represents a fundamental limitation—while magnesium oxide has conditional recommendations based on RCT data (albeit very low certainty evidence), magnesium glycinate exists in a clinical evidence vacuum for therapeutic use.
Theoretical Absorption Advantages
The rationale for glycinate formulations centers on alternative absorption pathways:
Dipeptide transport mechanism: A 1994 study in patients with ileal resection showed that magnesium diglycinate may be absorbed partially intact via dipeptide transporters in the proximal small intestine, achieving 23.5% absorption versus 11.8% for magnesium oxide in patients with severe malabsorption (p<0.05). 3
Earlier peak absorption: Isotope enrichment occurred 3.2 hours earlier with glycinate versus oxide (p<0.05), suggesting faster bioavailability. 3
Better tolerability: The chelated form was better tolerated by all patients, likely due to reduced osmotic/cathartic effects compared to magnesium oxide. 3
However, this single study involved only 12 patients with ileal resection—a highly specific population with severe malabsorption. The findings cannot be extrapolated to general clinical use.
Recent Animal and Observational Data
Recent preclinical studies suggest tissue-specific effects:
Muscle and brain accumulation: Rat studies show magnesium glycinate increases tissue magnesium levels in skeletal muscle and brain regions, with potential anxiolytic effects. 4, 5
Sleep quality: A 2025 RCT (n=155) showed modest improvement in Insomnia Severity Index scores with magnesium bisglycinate (250 mg elemental magnesium daily) versus placebo at 4 weeks, with small effect size (Cohen's d=0.2). 6 This represents the only human RCT data for glycinate formulations, but for a non-medical outcome.
Refractory hypomagnesemia: A 2026 case report described successful treatment of post-bariatric surgery hypomagnesemia with renal wasting using high-dose magnesium glycinate after failure of oxide and IV sulfate. 7 This is anecdotal evidence only.
Clinical Context and Practical Considerations
When magnesium supplementation is indicated (constipation, documented hypomagnesemia, short bowel syndrome):
For chronic idiopathic constipation: Use magnesium oxide 500 mg to 1.5 g daily, as this is the only formulation with RCT evidence, despite very low certainty. 2 Start at lower doses and titrate up. Avoid in creatinine clearance <20 mL/min due to hypermagnesemia risk. 2
For hypomagnesemia in malabsorption: The 2006 Gut guidelines recommend magnesium oxide 12-24 mmol daily (480-960 mg elemental magnesium) given at night when intestinal transit is slowest. 8 Magnesium glycinate may be considered if oxide causes intolerable diarrhea or fails to correct levels, based on limited evidence. 7, 3
For general supplementation: No evidence supports choosing glycinate over other formulations for healthy individuals or for outcomes like sleep, anxiety, or muscle function in clinical practice.
Important Caveats
- Cost differential: Glycinate formulations are typically more expensive than oxide or citrate without proven superior clinical outcomes
- Elemental magnesium content: Glycinate contains less elemental magnesium per gram than oxide, requiring larger doses or more capsules
- Renal function: All magnesium supplements require dose adjustment or avoidance in renal insufficiency, as systemic regulation depends on renal excretion 2, 8
- Drug interactions: Magnesium can interfere with absorption of bisphosphonates, tetracyclines, and quinolones
Bottom Line for Clinical Practice
Magnesium glycinate is a chelated supplement with theoretical absorption advantages and better GI tolerability than magnesium oxide, but it lacks clinical trial evidence for any therapeutic indication. It may be a reasonable alternative when magnesium oxide causes unacceptable diarrhea or fails in severe malabsorption states, but this represents off-label use based on mechanistic rationale rather than proven efficacy. For evidence-based magnesium therapy, magnesium oxide remains the only formulation with RCT support, albeit with very low certainty evidence. 2